The jury weighing fraud charges against former Theranos CEO Elizabeth Holmes will start their second week of deliberations Monday. Holmes faces 11 criminal charges alleging that she duped investors and patients by hailing her company’s blood-testing technology as a medical breakthrough when in fact it was prone to wild errors.
